HENRY J FUCHS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HENRY J FUCHS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HENRY J FUCHS. HENRY J FUCHS is EVP, Chief Medical Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and President, Worldwide R&D in BIOMARIN PHARMACEUTICAL INC ($BMRN) and President & CEO in Ardea Biosciences, Inc./DE ($IBPI) and Director in GENOMIC HEALTH INC ($GHDX) and in Mirati Therapeutics, Inc. ($MYG) and Director in Mirati Therapeutics, Inc. ($MYG).
Latest Insider Trading Transactions of HENRY J FUCHS
Sentiment: All, IBPI, BMRN, GHDX, MYG
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 5,000 | 132,450 | 138,976 | 134 K to 139 K (+3.73 %) |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 32.09 | 311 | 9,980 | 5,226 | 4.9 K to 5.2 K (+6.33 %) |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 10,000 | 374,600 | 37,934 | |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 5,000 | 132,450 | 10,225 | |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.50 | 15,000 | 1,357,500 | 136,422 | 151.4 K to 136.4 K (-9.91 %) |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 10,000 | 374,600 | 151,422 | 141.4 K to 151.4 K (+7.07 %) |
Sep 19 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 5,000 | 132,450 | 141,422 | 136.4 K to 141.4 K (+3.67 %) |
Jul 05 2017 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 32.55 | 307 | 9,993 | 4,915 | 4.6 K to 4.9 K (+6.66 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 603 | 22,588 | 47,331 | |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 9,397 | 352,012 | 47,934 | |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 5,000 | 132,450 | 15,225 | |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 603 | 54,270 | 136,422 | 137 K to 136.4 K (-0.44 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 603 | 22,588 | 137,025 | 136.4 K to 137 K (+0.44 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 9,397 | 845,730 | 136,422 | 145.8 K to 136.4 K (-6.44 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 5,000 | 450,000 | 145,819 | 150.8 K to 145.8 K (-3.32 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 9,397 | 352,012 | 150,819 | 141.4 K to 150.8 K (+6.64 %) |
Jun 20 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 5,000 | 132,450 | 141,422 | 136.4 K to 141.4 K (+3.67 %) |
Jun 20 2017 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | A | 31.53 | 10,000 | 315,300 | 10,000 | |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 90.72 | 2,036 | 184,706 | 136,422 | 138.5 K to 136.4 K (-1.47 %) |
May 19 2017 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Director | Option Exercise | A | 3.65 | 10,000 | 36,500 | 10,000 | |
May 17 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 91.50 | 2,036 | 186,294 | 138,458 | 140.5 K to 138.5 K (-1.45 %) |
May 17 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Grant | A | 70.30 | 302 | 21,232 | 140,494 | 140.2 K to 140.5 K (+0.22 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 31.49 | 317 | 9,982 | 4,608 | 4.3 K to 4.6 K (+7.39 %) |
Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | A | 87.42 | 64,030 | 5,597,503 | 64,030 | |
Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Grant | A | 0.00 | 19,790 | 0 | 140,192 | 120.4 K to 140.2 K (+16.44 %) |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 92.50 | 5,116 | 473,230 | 120,402 | 125.5 K to 120.4 K (-4.08 %) |
Mar 07 2017 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 93.95 | 2,924 | 274,710 | 125,518 | 128.4 K to 125.5 K (-2.28 %) |
Jan 04 2017 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 29.39 | 340 | 9,993 | 4,291 | 4 K to 4.3 K (+8.61 %) |
Nov 29 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 15,000 | 397,350 | 35,225 | |
Nov 29 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 87.40 | 15,000 | 1,310,988 | 113,878 | 128.9 K to 113.9 K (-11.64 %) |
Nov 29 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 15,000 | 397,350 | 128,878 | 113.9 K to 128.9 K (+13.17 %) |
Oct 04 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 28.92 | 345 | 9,977 | 3,951 | 3.6 K to 4 K (+9.57 %) |
Aug 30 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 26.49 | 15,000 | 397,350 | 50,225 | |
Aug 30 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 95.06 | 15,000 | 1,425,924 | 113,878 | 128.9 K to 113.9 K (-11.64 %) |
Aug 30 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 26.49 | 15,000 | 397,350 | 128,878 | 113.9 K to 128.9 K (+13.17 %) |
Jul 06 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 26.74 | 373 | 9,974 | 3,606 | 3.2 K to 3.6 K (+11.54 %) |
Jun 14 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | A | 26.18 | 10,000 | 261,800 | 10,000 | |
Jun 07 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 90.00 | 2,036 | 183,240 | 113,878 | 115.9 K to 113.9 K (-1.76 %) |
May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 26.49 | 15,000 | 397,350 | 65,225 | |
May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 87.34 | 5,000 | 436,700 | 115,914 | 120.9 K to 115.9 K (-4.14 %) |
May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 88.04 | 10,000 | 880,400 | 120,914 | 130.9 K to 120.9 K (-7.64 %) |
May 31 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 26.49 | 15,000 | 397,350 | 130,914 | 115.9 K to 130.9 K (+12.94 %) |
May 19 2016 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Director | Option Exercise | A | 15.72 | 10,000 | 157,200 | 10,000 | |
May 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 82.71 | 2,036 | 168,398 | 115,914 | 118 K to 115.9 K (-1.73 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 80.80 | 3,131 | 252,985 | 117,950 | 121.1 K to 118 K (-2.59 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 51.26 | 415 | 21,275 | 121,081 | 120.7 K to 121.1 K (+0.34 %) |
Apr 04 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 25.48 | 392 | 9,988 | 3,233 | 2.8 K to 3.2 K (+13.80 %) |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | A | 83.43 | 44,340 | 3,699,286 | 44,340 | |
Mar 17 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 19,790 | 0 | 120,666 | 100.9 K to 120.7 K (+19.62 %) |
Mar 07 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 89.57 | 3,043 | 272,562 | 100,876 | 103.9 K to 100.9 K (-2.93 %) |
Mar 02 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 81.87 | 56,464 | 4,622,708 | 103,919 | 160.4 K to 103.9 K (-35.21 %) |
Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 7,437 | 0 | 160,383 | 152.9 K to 160.4 K (+4.86 %) |
Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 59,520 | 0 | 152,946 | 93.4 K to 152.9 K (+63.71 %) |
Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 20,580 | 0 | 93,426 | 72.8 K to 93.4 K (+28.25 %) |
Jan 05 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 35.20 | 284 | 9,997 | 2,841 | 2.6 K to 2.8 K (+11.11 %) |
Oct 05 2015 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 21.34 | 468 | 9,987 | 2,557 | 2.1 K to 2.6 K (+22.40 %) |
Jul 06 2015 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 27.34 | 365 | 9,979 | 2,089 | 1.7 K to 2.1 K (+21.17 %) |
Jun 15 2015 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | A | 26.01 | 10,000 | 260,100 | 10,000 | |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 122.32 | 1,864 | 228,001 | 72,846 | 74.7 K to 72.8 K (-2.49 %) |
Jun 08 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 120.46 | 2,036 | 245,257 | 74,710 | 76.7 K to 74.7 K (-2.65 %) |
May 22 2015 | MYG | Mirati Therapeutic ... | FUCHS HENRY J | Director | Option Exercise | A | 25.84 | 15,000 | 387,600 | 15,000 | |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 124.78 | 1,864 | 232,584 | 76,746 | 78.6 K to 76.7 K (-2.37 %) |
May 19 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 122.78 | 2,036 | 249,980 | 78,610 | 80.6 K to 78.6 K (-2.52 %) |
May 14 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 121.37 | 1,434 | 174,038 | 80,646 | 82.1 K to 80.6 K (-1.75 %) |
May 14 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 121.09 | 1,566 | 189,627 | 82,080 | 83.6 K to 82.1 K (-1.87 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 121.64 | 2,869 | 348,988 | 83,646 | 86.5 K to 83.6 K (-3.32 %) |
May 12 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 121.66 | 3,131 | 380,917 | 86,515 | 89.6 K to 86.5 K (-3.49 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | S | 114.59 | 414 | 47,442 | 89,646 | 89.2 K to 89.6 K (+0.46 %) |
May 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 51.26 | 1,425 | 73,050 | 90,060 | 88.6 K to 90.1 K (+1.61 %) |
Apr 03 2015 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 30.43 | 328 | 9,981 | 1,724 | 1.4 K to 1.7 K (+23.50 %) |
Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 5,845 | 125,726 | 2,000 | |
Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | M | 21.51 | 34,155 | 734,674 | 0 | |
Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Sell | S | 123.57 | 41,315 | 5,105,166 | 88,635 | 130 K to 88.6 K (-31.79 %) |
Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 21.51 | 5,845 | 125,726 | 129,950 | 124.1 K to 130 K (+4.71 %) |
Mar 18 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Buy | M | 21.51 | 34,155 | 734,674 | 124,105 | 90 K to 124.1 K (+37.97 %) |
Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Option Exercise | A | 108.36 | 30,500 | 3,304,980 | 30,500 | |
Mar 05 2015 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 13,400 | 0 | 89,950 | 76.6 K to 90 K (+17.50 %) |
May 10 2004 | IBPI | Ardea Biosciences, ... | FUCHS HENRY J | President & CEO | Option Exercise | A | 13.06 | 100,000 | 1,306,000 | 368,333 | |
Feb 04 2004 | IBPI | Ardea Biosciences, ... | FUCHS HENRY J | President & CEO | Option Exercise | A | 16.49 | 60,000 | 989,400 | 268,333 |